ES2197018A1 - Nuevo uso terapeutico de los extractos de polypodium. - Google Patents

Nuevo uso terapeutico de los extractos de polypodium.

Info

Publication number
ES2197018A1
ES2197018A1 ES200201345A ES200201345A ES2197018A1 ES 2197018 A1 ES2197018 A1 ES 2197018A1 ES 200201345 A ES200201345 A ES 200201345A ES 200201345 A ES200201345 A ES 200201345A ES 2197018 A1 ES2197018 A1 ES 2197018A1
Authority
ES
Spain
Prior art keywords
therapeutic use
new therapeutic
polypodium extracts
polypodium
extracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200201345A
Other languages
English (en)
Other versions
ES2197018B1 (es
Inventor
Almagro Eliseo Quintanilla
Alperi Joaquin Diaz
Zapata Jose Pardo
Ortells Jose Miguel Sempere
Panos Ana Segura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Especialidades Farmaceuticas Centrum SA
Original Assignee
Especialidades Farmaceuticas Centrum SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200201345A priority Critical patent/ES2197018B1/es
Application filed by Especialidades Farmaceuticas Centrum SA filed Critical Especialidades Farmaceuticas Centrum SA
Priority to EP03730214A priority patent/EP1637148A1/en
Priority to AU2003240850A priority patent/AU2003240850A1/en
Priority to PCT/ES2003/000272 priority patent/WO2003103695A1/es
Priority to US10/516,825 priority patent/US20060093690A1/en
Priority to CA002488356A priority patent/CA2488356A1/en
Priority to CNA038186926A priority patent/CN1678332A/zh
Priority to KR10-2004-7019739A priority patent/KR20050014848A/ko
Priority to JP2004510814A priority patent/JP2005528452A/ja
Publication of ES2197018A1 publication Critical patent/ES2197018A1/es
Application granted granted Critical
Publication of ES2197018B1 publication Critical patent/ES2197018B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Nuevo uso de los extractos de Polypodium, obtenibles por extracción con un disolvente con una constante dieléctrica mayor a 20, para tratamiento de la enfermedad de La Peyronie.
ES200201345A 2002-06-06 2002-06-06 Nuevo uso terapeutico de los extractos de polypodium. Expired - Fee Related ES2197018B1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES200201345A ES2197018B1 (es) 2002-06-06 2002-06-06 Nuevo uso terapeutico de los extractos de polypodium.
AU2003240850A AU2003240850A1 (en) 2002-06-06 2003-06-05 Novel therapeutic use of polypodium extracts
PCT/ES2003/000272 WO2003103695A1 (es) 2002-06-06 2003-06-05 Nuevo uso terapéutico de los extractos de polypodium
US10/516,825 US20060093690A1 (en) 2002-06-06 2003-06-05 Novel therapeutic use of polypodium extracts
EP03730214A EP1637148A1 (en) 2002-06-06 2003-06-05 Novel therapeutic use of polypodium extracts
CA002488356A CA2488356A1 (en) 2002-06-06 2003-06-05 Novel therapeutic use of polypodium extracts
CNA038186926A CN1678332A (zh) 2002-06-06 2003-06-05 水龙骨属提取物的新型治疗用途
KR10-2004-7019739A KR20050014848A (ko) 2002-06-06 2003-06-05 미역고사리속 추출물의 신규한 치료적 용도
JP2004510814A JP2005528452A (ja) 2002-06-06 2003-06-05 ポリポディウム抽出物の新規な治療用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201345A ES2197018B1 (es) 2002-06-06 2002-06-06 Nuevo uso terapeutico de los extractos de polypodium.

Publications (2)

Publication Number Publication Date
ES2197018A1 true ES2197018A1 (es) 2003-12-16
ES2197018B1 ES2197018B1 (es) 2005-10-01

Family

ID=29724726

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201345A Expired - Fee Related ES2197018B1 (es) 2002-06-06 2002-06-06 Nuevo uso terapeutico de los extractos de polypodium.

Country Status (9)

Country Link
US (1) US20060093690A1 (es)
EP (1) EP1637148A1 (es)
JP (1) JP2005528452A (es)
KR (1) KR20050014848A (es)
CN (1) CN1678332A (es)
AU (1) AU2003240850A1 (es)
CA (1) CA2488356A1 (es)
ES (1) ES2197018B1 (es)
WO (1) WO2003103695A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100807758B1 (ko) * 2006-04-03 2008-02-28 부경대학교 산학협력단 항염증 활성을 갖는 미역 추출물
WO2015200333A1 (en) * 2014-06-25 2015-12-30 Whitten Jeffrey P Polypodium leucotomos extract preparation and use thereof
CN107556398A (zh) * 2017-09-19 2018-01-09 李仲昆 一种水龙骨多糖提取物及其制备方法
KR20200037468A (ko) 2018-09-30 2020-04-09 제토바이오 주식회사 구연산을 통한 미생물 생존내구력 강화와 유산균 및 인산가용화균으로 구성된 복합미생물 대량생산 액상비료 및 그 제조방법

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
BR9801985A (pt) * 1998-04-30 2000-02-08 Cristiano Alberto Ribeiro Sant Composição cremosa aplicada na terapeutica da doença de peyronie.
WO2000007587A1 (en) * 1998-08-03 2000-02-17 Easterling W Jerry Composition and method for treating peyronie's disease and other sub-dermal plaque manifestation disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395223A (en) * 1965-05-13 1968-07-30 Carter Wallace Fern extract for treating gastric ulcers
US4206222A (en) * 1977-06-23 1980-06-03 Societe Civile Particuliere De Brevets Suffren Method for preparing a substance having properties against collagen diseases and products obtained
DE69527742T2 (de) * 1994-05-06 2002-12-05 Especialidades Farmaceuticas Centrum, S.A. Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.
EP0875250A1 (de) * 1997-04-29 1998-11-04 Heilmittelbetrieb Isernhagen GmbH Verwendung eines Extraktes aus Salvia officinalis bei der Bekämpfung der Dupuytren-Kontraktur
US6228366B1 (en) * 1998-07-29 2001-05-08 Helsint, S.A.L. Water-soluble fractions of Phlebodium decumanum and its use as nutritional supplement in AIDS and cancer patients

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
EP0503208A1 (en) * 1991-03-08 1992-09-16 Maracuyama International, S.A. Procedure for obtaining a natural water-soluble extract from the leaves and/or rhizomes of various immunologically active ferns
BR9801985A (pt) * 1998-04-30 2000-02-08 Cristiano Alberto Ribeiro Sant Composição cremosa aplicada na terapeutica da doença de peyronie.
WO2000007587A1 (en) * 1998-08-03 2000-02-17 Easterling W Jerry Composition and method for treating peyronie's disease and other sub-dermal plaque manifestation disorders
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CORRALES PADILLA, H. et al. "A new agent (Hydrophilic fraction of Polypodium leucotomos) for management of psoriasis". International Journal of Dermatology, 1974, Vol. 13, pßginas 276-282. *
TUOMINEN, M. et al. "Effects of Calaguala and an active principle, Adenosine, on platelet activating factor". Planta MÚdica, 1992, Vol. 58, pßginas 306-310. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease

Also Published As

Publication number Publication date
JP2005528452A (ja) 2005-09-22
KR20050014848A (ko) 2005-02-07
CN1678332A (zh) 2005-10-05
WO2003103695A1 (es) 2003-12-18
US20060093690A1 (en) 2006-05-04
EP1637148A1 (en) 2006-03-22
AU2003240850A1 (en) 2003-12-22
ES2197018B1 (es) 2005-10-01
CA2488356A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
AR037109A1 (es) Uso de flibanserina
BR0110366B1 (pt) êmbolo para uma seringa e seringa retrátil de uso único.
AR040118A2 (es) Metodo para dispensar anteojos electroactivos
DK1459749T3 (da) (S,S)-reboxetin til behandling af inkontinens
BR0212684B1 (pt) seringa retrátil de utilização única.
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
AR028372A1 (es) Dispositivos de administracion de drogas de liberacion sostenida, metodos de uso y metodos de fabricacion de los mismos
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
BRPI0407917A (pt) dispositivo de limpeza
ITNA20000036A0 (it) Nuovi approcci terapeutici per il trattamento della forfora.
ES2197018A1 (es) Nuevo uso terapeutico de los extractos de polypodium.
IT1318365B1 (it) Dispositivo di protezione per l'ago per siringa ad uso medicale.
UY26265A1 (es) Compuestos calciolíticos
BR0210632A (pt) Tratamento de doença parasìtica
PT1315496E (pt) Tratamento de desordens inflamatorias
ITRM20020492A1 (it) Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
SV2002000065A (es) Dosis mensuales para el tratamiento de las infecciones por streptococcus pneumoniae ref. x-12423
IT1318509B1 (it) Polimeri reticolati, utili per uso farmaceutico, medicale e cosmetico.
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
BR0209400A (pt) Composição para cuidado de tecido, processo para o tratamento de tecido, e, uso de uma composição
FR2840179B1 (fr) Receptacle de douche notamment pour personne a mobilite reduite
ES1044675Y (es) Dispositivo de comunicacion para personas discapacitadas.
ES1044676Y (es) Dispositivo de comunicacion para personas discapacitadas.
ES1053675Y (es) Andador perfeccionado para personas discapacitadas.
ES1045126Y (es) Mascarilla para aerosoles con dispositivo orientable para uso medico.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031216

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2197018B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20181004